Reported Cases of Spotted Fever Rickettsiosis Rarely Confirmed
Only 1.0 percent of reported cases of spotted fever rickettsioses (SFR) meet the confirmed case definition.
Vector-borne Disease
Neurologic Manifestations of Zika Virus Infection: What We Know So Far
Jonathan Miner, MD, PhD, and Karin Nielsen-Saines, MD, MPH, discuss the latest insights about neurologic complications of ZVI and knowledge gaps that still exist in this field.
Dengue Vaccine Candidate TAK-003 Looks Promising in Phase 3 Trial
The TIDES trial is investigating the safety and efficacy of 2 doses of TAK-003 in preventing dengue fever caused by any of the 4 dengue virus serotypes.
Novel Malaria Vaccine Shows Activity Only at Peak Titers
A malaria transmission-blocking vaccine, Pfs25H-EPA in Alhydrogel®, was well tolerated and safe and induced significant blockage of parasite transmission, but this activity was only seen at peak titers after 4 vaccine doses.
Next post in Vector-borne Illnesses
